AR008171A1 - Promotor regulado por hierro, una molecula de adn recombinante, un vector recombinante, una celula anfitrion recombinante, una composicion para su uso enla induccion de una respuesta inmune en un animal, celula anfitrion recombinante y un metodo para producir una celula huesped recombinante - Google Patents
Promotor regulado por hierro, una molecula de adn recombinante, un vector recombinante, una celula anfitrion recombinante, una composicion para su uso enla induccion de una respuesta inmune en un animal, celula anfitrion recombinante y un metodo para producir una celula huesped recombinanteInfo
- Publication number
- AR008171A1 AR008171A1 ARP970104095A ARP970104095A AR008171A1 AR 008171 A1 AR008171 A1 AR 008171A1 AR P970104095 A ARP970104095 A AR P970104095A AR P970104095 A ARP970104095 A AR P970104095A AR 008171 A1 AR008171 A1 AR 008171A1
- Authority
- AR
- Argentina
- Prior art keywords
- recombinant
- metod
- cell
- animal
- immune response
- Prior art date
Links
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 title abstract 4
- 108020004511 Recombinant DNA Proteins 0.000 title abstract 2
- 230000028993 immune response Effects 0.000 title abstract 2
- 229910052742 iron Inorganic materials 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000001105 regulatory effect Effects 0.000 title abstract 2
- 239000013598 vector Substances 0.000 title abstract 2
- 230000006698 induction Effects 0.000 title 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 2
- 102000053602 DNA Human genes 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 150000007523 nucleic acids Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
- C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se provee un promotor regulado por hierro. El promotor comprende la secuencia de ADN mostrada en la Fig.1 o un fragmento de la misma la cualincluye la secuencia de los residuos 284 a 409, o una secuencia de ácido nucleico funcionalmente equivalente. También se proveen vectores y célulasanfitriones recombinantes que incluyen el promotor y las composiciones para uso de inducción de una respuesta inmune en un animal. Se proveen además unamolécula de ADN recombinante y un método paraproducir una célula huésped recombinante.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPO2164A AUPO216496A0 (en) | 1996-09-06 | 1996-09-06 | Inducible promoters |
| AUPO2454A AUPO245496A0 (en) | 1996-09-19 | 1996-09-19 | Site-specific chromosomal integration system |
| AUPO7801A AUPO780197A0 (en) | 1997-07-09 | 1997-07-09 | Site-specific chromosomal integration system incorporating inducible promoter |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR008171A1 true AR008171A1 (es) | 1999-12-09 |
Family
ID=27157946
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970104095A AR008171A1 (es) | 1996-09-06 | 1997-09-08 | Promotor regulado por hierro, una molecula de adn recombinante, un vector recombinante, una celula anfitrion recombinante, una composicion para su uso enla induccion de una respuesta inmune en un animal, celula anfitrion recombinante y un metodo para producir una celula huesped recombinante |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0964924A4 (es) |
| AR (1) | AR008171A1 (es) |
| BR (1) | BR9711692A (es) |
| CA (1) | CA2265883A1 (es) |
| NZ (1) | NZ334649A (es) |
| UY (1) | UY24698A1 (es) |
| WO (1) | WO1998010064A1 (es) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69132058D1 (de) * | 1990-12-18 | 2000-04-20 | Gen Hospital Corp | Verbesserte impfstoffe |
| EP0692031B1 (en) * | 1993-02-22 | 2007-04-11 | The General Hospital Corporation | Heterologous antigens in live cell vaccine strains |
-
1997
- 1997-08-08 BR BR9711692-0A patent/BR9711692A/pt unknown
- 1997-08-08 CA CA002265883A patent/CA2265883A1/en not_active Abandoned
- 1997-08-08 WO PCT/AU1997/000503 patent/WO1998010064A1/en not_active Application Discontinuation
- 1997-08-08 NZ NZ334649A patent/NZ334649A/xx unknown
- 1997-08-08 EP EP97933590A patent/EP0964924A4/en not_active Withdrawn
- 1997-09-05 UY UY24698A patent/UY24698A1/es not_active Application Discontinuation
- 1997-09-08 AR ARP970104095A patent/AR008171A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ334649A (en) | 2000-08-25 |
| UY24698A1 (es) | 1998-02-12 |
| CA2265883A1 (en) | 1998-03-12 |
| EP0964924A4 (en) | 2001-04-18 |
| BR9711692A (pt) | 2000-10-24 |
| WO1998010064A1 (en) | 1998-03-12 |
| EP0964924A1 (en) | 1999-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE270337T1 (de) | Materialen und methoden im zusammenhang mit bindung und präsentation von substanzen auf zelloberflächen | |
| AR018346A1 (es) | Peptidos mutantes promotores de la inmunidad celular t, composiciones farmaceuticas y vacunas formuladas con dichos peptidos para el tratamiento decanceres; uso de dichos peptidos, metodo para identificar dichos peptidos y secuencias de adn que codifican dichos peptidos mutantes y vectores y plasmid | |
| DE69435292D1 (de) | Verfahren zur herstellung von immunogenen hla-a2.1-bindenden peptiden | |
| ATE178652T1 (de) | Verbessertes verfahren zur herstellung von endotoxinbindungsproteinen | |
| ATE250133T1 (de) | Verktorvermittelte genominsertion und expression von dna in bcg | |
| NL980006I1 (nl) | Antigeen-preparaten en isolering van dergelijke preparaten. | |
| MX9203519A (es) | Metodo de recombinacion para la produccion de inhibidores de proteasa de serina y secuencias de adn utiles para los mismos. | |
| ATE189961T1 (de) | Impfstoff gegen mycobakterielle infektionen | |
| ES2085928T3 (es) | Gen y secuencia proteica del mk humano. | |
| ATE121754T1 (de) | Vakzine gegen bordetella. | |
| NO862690D0 (no) | Monoklonale antistoffer og antigener for humane ikke-liten-celle lungekarcinomer (nsclc). | |
| DK0594771T3 (da) | Cycloheximidresistens i nukleotidsekvenser og -proteiner | |
| ATE356831T1 (de) | Neuer galaninrezeptor | |
| AR008171A1 (es) | Promotor regulado por hierro, una molecula de adn recombinante, un vector recombinante, una celula anfitrion recombinante, una composicion para su uso enla induccion de una respuesta inmune en un animal, celula anfitrion recombinante y un metodo para producir una celula huesped recombinante | |
| NZ333265A (en) | Vaccine containing peroxiredoxin and/or beta-tubulin of fluke origin to immunise against parasitic infestation of helminths in mammals | |
| ES554327A0 (es) | Un procedimiento para preparar un plasmido recombinante | |
| ATE349465T1 (de) | Zusammensetzungen sowie verfahren zur hocheffizienten transfektion | |
| ATE174963T1 (de) | Klonierung und expression eines rhoptry- assoziierten proteins aus p. falciparum | |
| DK43991A (da) | Allele varianter af plasmodium falciparum merozoitoverfladeantigen | |
| SE9604439D0 (sv) | New receptor | |
| IT1177378B (it) | Vettore plasmidico psm112 ad espressione in bacillus subtilis | |
| CA2025938A1 (en) | Cloning of the gene which codes for the pilinic subunit fim3 of bordetella pertussis | |
| DE69128095D1 (de) | Azelluläre impfstoffe |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |